Clinical Trial: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

Brief Summary: Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Detailed Summary: Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Sponsor: GlaxoSmithKline

Current Primary Outcome: Mean of composite satisfaction score (CSS) of OPSAT-QTM [ Time Frame: 0day ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Mean of subscale satisfaction scores of OPSAT-QTM [ Time Frame: oday ]

Original Secondary Outcome: Same as current

Information By: GlaxoSmithKline

Dates:
Date Received: June 3, 2010
Date Started: June 2008
Date Completion:
Last Updated: February 17, 2011
Last Verified: February 2011